Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Krasimir Antonov"'
Publikováno v:
Journal of Clinical and Diagnostic Research, Vol 11, Iss 8, Pp OC15-OC20 (2017)
Introduction: Hepatitis C Virus (HCV) relies on host lipids for its life cycle contributing to lipid abnormalities and hepatic steatosis. Disease progression is influenced by viral factors interacting with host immune and metabolic pathways. The
Externí odkaz:
https://doaj.org/article/8215c2036b4848f29f2cf20a37c1a879
Autor:
Assya Krasteva, Vladimir E. Panov, Dejan Jelev, Krasimir Antonov, Aneta Ivanova, Zahariy Krastev
Publikováno v:
Journal of IMAB, Vol 19, Iss 4, Pp 355-358 (2013)
Hepatitis B virus is the most important infectious hazard in dental profession. Vectors of HBV infection are not only blood, but also saliva, nasopharyngeal secretions, crevicular fluid.The aim of the study was to evaluate serum and salivary HBV DNA
Externí odkaz:
https://doaj.org/article/91cee5eb45b94ad9b48891b68a5ce15b
Publikováno v:
Journal of IMAB, Vol 19, Iss 3, Pp 442-447 (2013)
Introduction: IP-10 it has been studied as a predictor of treatment response in chronic HCV infected patients. The data for the HBV infection are not enough.Aim: To compare IP-10 levels in patients with chronic HBV /CHB/ and HCV infection /CHC/ and t
Externí odkaz:
https://doaj.org/article/6589e6c790a741f99d6c7e776c027072
Publikováno v:
Journal of IMAB, Vol 18, Iss 4, Pp 251-254 (2012)
Persistent undiagnosed fever remains a common problem in clinical practice. It is a fact that dental sepsis is one potential cause of persistent fever that can escape detection (Siminoski, K., 1993). We present a 50 years old woman with chronic hepat
Externí odkaz:
https://doaj.org/article/d86250335bb545d6b4e830310cf3fc0e
Autor:
Krasimir Antonov, Dejan Jelev, Radina Ivanova, Assen Alexiev, Sonya Dragneva, Luydmila Mateva
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 193-196 (2011)
It is well known that NAFLD, as well as diabetes mellitus (DM), correlated with the progression of liver fibrosis in chronic hepatitis C (CHC). The impact of NAFLD overlap in chronic hepatitis B (CHB) is not well established. Aim. In this study we co
Externí odkaz:
https://doaj.org/article/4596a996b091483682ccf6e12344c161
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 154-157 (2011)
Objective: IFN-based therapy induces long-term remission in ~20% of CHB-patients. Identification of predictors of treatment response can facilitate the clinical decision. Methods: 168 CHB-patients treated with IFN-based therapy were studied. Predicto
Externí odkaz:
https://doaj.org/article/6530c814ad4043a3a9c5c6acb3d4a629
Autor:
Pavlina Dzekova-Vidimliski, Igor G. Nikolov, Nadica Matevska-Geshkovska, Yana Boyanova, Nina Nikolova, Grigore Romanciuc, Dan Dumitrascu, Viktorija Caloska-Ivanova, Nenad Joksimovic, Krasimir Antonov, Lyudmila Mateva, Lionel Rostaing, Aleksandar Dimovski, Aleksandar Sikole
Publikováno v:
Biomolecules & Biomedicine, Vol 15, Iss 4 (2015)
The genome-wide association studies have identified a strong association between interleukin 28B (IL28B) gene polymorphisms and the response to treatment in patients with hepatitis C virus (HCV) infection. The aim of the study was to evaluate the ass
Externí odkaz:
https://doaj.org/article/8e75b50f61904c01b0706e3a288be778
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 197-199 (2011)
Objective: The combined PEG-IFN alpha and RBV therapy achieved SVR in 40 - 50% of patients infected with HCV genotype 1. Identification of virological and host paramemeters predicting SVR will be useful to tailor therapy. Methods: 71 patients with ch
Externí odkaz:
https://doaj.org/article/082bcb1b555047e6a53d1d61a667ebce
Publikováno v:
Journal of IMAB, Vol 17, Iss 1, Pp 152-153 (2011)
Objective: HBV-infection is intermediate-endemic in Bulgaria. There is a trend for decreasing of HBsAg-carrier rate in the last decades, but prevalence remains higher in some specific ethnic communities. Current data regarding high-endemic sources of
Externí odkaz:
https://doaj.org/article/c70ae812e75548bf97209b3fdc884d6c
Publikováno v:
Journal of Medical and Dental Practice. 8:1339-1348